| Date | Form | Description | Docs | XBRL | Pages |
| 09/14/11 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
79 | |
| 06/14/11 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
56 | |
| 03/17/11 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
52 | |
| 09/14/10 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
58 | |
| 09/14/10 | 10-Q/A | Quarterly report pursuant to sections 13 or 15(d) |
|
14 | |
| 06/14/10 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
58 | |
| 03/17/10 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
47 | |
| 09/09/09 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
33 | |
| 06/18/09 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
30 | |
| 06/10/09 | NT 10-Q | Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB |
|
3 |
Latest News & Events
Anixa Biosciences and OntoChem Have Synthesized Four Potential Covid-19 Drugs for Testing in Biological Assays
Read More...Anixa Biosciences and OntoChem Announce Discovery of First Covid-19 Therapeutic Candidate
Read More...Anixa Biosciences Announces Publication of Peer-Reviewed Journal Article in Biomarker Insights Highlighting Cchek™ Liquid Biopsy Technology
Read More...